Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
52.72M | 53.19M | 58.57M | 61.16M | 61.60M | 47.81M | Gross Profit |
23.02M | 22.83M | 24.05M | 25.75M | 24.48M | 19.63M | EBIT |
2.73M | 1.54M | 1.49M | 5.32M | 5.39M | 3.75M | EBITDA |
-19.00K | -1.21M | 2.69M | 5.34M | 6.94M | 5.13M | Net Income Common Stockholders |
-2.60M | -3.53M | 514.00K | 3.11M | 4.33M | 3.17M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
2.63M | 3.14M | 1.65M | 840.00K | 6.56M | 3.67M | Total Assets |
13.71M | 36.14M | 45.54M | 47.85M | 33.55M | 28.31M | Total Debt |
602.00K | 3.92M | 7.28M | 8.22M | 3.96M | 4.70M | Net Debt |
-2.03M | 781.00K | 5.63M | 7.38M | -2.60M | 1.03M | Total Liabilities |
5.25M | 14.09M | 20.06M | 22.17M | 13.46M | 12.74M | Stockholders Equity |
8.47M | 22.05M | 25.48M | 25.68M | 20.09M | 15.57M |
Cash Flow | Free Cash Flow | ||||
5.57M | 5.42M | 4.67M | -508.00K | 4.17M | 805.00K | Operating Cash Flow |
5.79M | 6.03M | 5.81M | 1.22M | 5.41M | 6.54M | Investing Cash Flow |
-413.00K | -608.00K | -2.64M | -8.09M | -1.07M | -5.49M | Financing Cash Flow |
-4.60M | -3.95M | -2.35M | 1.16M | -1.46M | 2.25M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | £116.26B | 23.71 | 30.27% | 3.18% | -0.76% | -12.83% | |
77 Outperform | £14.99B | 11.78 | 11.89% | 3.02% | -0.38% | 14.68% | |
66 Neutral | £70.65B | 23.59 | 5.92% | 7.31% | -5.19% | ― | |
64 Neutral | $8.82B | 14.70 | 4.78% | 173.90% | 3.26% | 2.11% | |
64 Neutral | £233.85M | 4.47 | 8.15% | 9.66% | -5.28% | 148.54% | |
57 Neutral | £24.23M | ― | -10.61% | 1.27% | -6.61% | -319.08% | |
53 Neutral | £362.44M | ― | -2.48% | 4.17% | -16.16% | 80.50% |
Creightons has announced the promotion of its Chief Financial Officer, Mohammed Qadeer, to the Board of Directors, effective May 1, 2025. Qadeer, who joined the company in 2022, has a strong background in finance and accounting, and his promotion is seen as a positive step for the company’s leadership team.
Spark’s Take on GB:CRL Stock
According to Spark, TipRanks’ AI Analyst, GB:CRL is a Neutral.
Creightons’ overall stock score reflects its mixed financial performance with strong cash flow but declining revenues and negative profitability. Technical indicators suggest a bearish trend, while valuation metrics indicate challenges due to the negative P/E ratio. However, recent corporate events and strategic moves to AIM are positive, offering potential for improved investor sentiment.
To see Spark’s full report on GB:CRL stock, click here.
Creightons plc announced that Paul Watts, a Non-Executive Director, has acquired 107,000 ordinary shares at a price of £0.295 each. This transaction highlights the confidence of the company’s leadership in its market position and potential growth, which could positively impact stakeholder perceptions.
Creightons has announced the admission of its entire issued share capital to trading on AIM, a market operated by the London Stock Exchange. This move marks a significant shift from the Main Market’s Equity Shares category and is expected to enhance the company’s visibility and accessibility to investors.
Creightons plc has announced the appointment of Mrs. Jemima Bird as an Independent Non-Executive Director, effective from March 31, 2025. Mrs. Bird, who will also chair the Remuneration Committee, brings extensive experience from her roles in various companies, which is expected to contribute significantly to Creightons’ board and future development.
Creightons plc announced a shareholding transaction involving Paul Forster, a Non-Executive Director, who transferred 200,000 ordinary shares to his wife, Clare Forster. This transaction, which was conducted outside a trading venue, does not alter Mr. Forster’s beneficial holding, which remains at 951,318 shares, representing 1.4% of the company’s issued share capital.
Creightons PLC, a company involved in the beauty and personal care industry, has announced the results of its General Meeting where shareholders approved a resolution to delist its ordinary shares from the Main Market of the London Stock Exchange and move them to AIM. This strategic shift is expected to take effect on March 31, 2025, and is aimed at potentially enhancing the company’s market positioning and operational flexibility. The decision reflects a significant change in the company’s trading platform, which could have implications for its stakeholders.
Creightons PLC has announced its intention to transition its Ordinary Shares from the London Stock Exchange’s main market to AIM, an internationally recognized market operated by the London Stock Exchange and designed for smaller companies. The move aims to reduce costs and regulatory burdens, as AIM offers a more flexible regulatory regime better suited to the company’s size, enhancing shareholder value and allowing management to focus more on strategic objectives.